Suwon, South Korea

Yoo-Kyung Goh

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aptabio Therapeutics Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoo-Kyung Goh. Retrieved from https://idiyas.com/inventor/yoo-kyung-goh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Yoo-Kyung GOH

Introduction: Yoo-Kyung GOH is a pioneering inventor hailing from Suwon-si, South Korea. Her groundbreaking work in the field of technology has left a lasting impact on the industry.

Latest Patents: Yoo-Kyung GOH holds several patents in the realm of artificial intelligence and robotics, showcasing her dedication to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Yoo-Kyung GOH has worked with some of the leading tech companies in South Korea, contributing significantly to the development of cutting-edge technologies.

Collaborations: Throughout her career, Yoo-Kyung GOH has collaborated with top researchers and engineers, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: Yoo-Kyung GOH's passion for innovation and her relentless drive to create have solidified her position as a trailblazer in the world of technology, inspiring future generations of inventors to dream big and push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…